C. Whitton

发表

International collaborative study to establish the 3rd International Standard for Streptokinase

C. Longstaff, D. Sands, C. Whitton, 2004, Journal of thrombosis and haemostasis : JTH.

How do we assure the quality of biological medicines?

R. Stebbings, C. Longstaff, C. Whitton, 2009, Drug discovery today.

The Haemostatic Balance – Astrup Revisited

P. Gaffney, C. Whitton, T. Edgell, 1999, Pathophysiology of Haemostasis and Thrombosis.

A Collaborative Study to Establish the 2nd International Standard for Fibrinogen, Plasma

P. Gaffney, A. Hubbard, D. Sands, 2000, Thrombosis and Haemostasis.

A reunification of the US ("NIH") and International Unit into a single standard for Thrombin.

C. Longstaff, D. Sands, C. Whitton, 2005, Thrombosis and haemostasis.

Regulatory frameworks in developing countries

C. Longstaff, C. Whitton, C. Thelwell, 2005, Nature Biotechnology.

A reunification of the US (“NIH”) and International Unit into a single standard for Thrombin

C. Longstaff, D. Sands, C. Whitton, 2005, Thrombosis and Haemostasis.

A proposed reference method for plasminogen activators that enables calculation of enzyme activities in SI units

C. Longstaff, C. Whitton, 2004, Journal of thrombosis and haemostasis : JTH.

High and constant plasma levels of tissue plasminogen activator and PEG-hirudin can be achieved by subcutaneous delivery.

J. Humphries, P. Gaffney, K. Burnand, 1997, Thrombosis research.

The poor quality of streptokinase products in use in developing countries

C. Longstaff, C. Whitton, C. Thelwell, 2005, Journal of thrombosis and haemostasis : JTH.

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva , 8-12 October 2007 A Proposed 1 st WHO International Standard for the measurement of Tissue Plasminogen Activator ( tPA ) Antigen in Plasma 94 / 730

P. Rigsby, C. Longstaff, C. Whitton, 2007 .